Roivant's lung disease drug fails mid-stage trial-February 2024-www.financetom.com

Roivant's lung disease drug fails mid-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Roivant's lung disease drug fails mid-stage trial

Dec 3, 2024 4:35 AM

Dec 3 (Reuters) - Roivant said on Tuesday its

drug did not meet the main goal in a mid-stage trial evaluating

it in patients with a type of lung disease.

(Reporting by Christy Santhosh in Bengaluru; Editing by

Shinjini Ganguli)

Previous page： PVR Chairman Ajay Bijli expects Inox merger to be completed this fiscal Next page： Khelraja signs Esha Gupta as brand ambassador

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

PVR Chairman Ajay Bijli expects Inox merger to be completed this fiscal

Dec 16, 2022

Leading film exhibitor PVR Ltd's Chairman Ajay Bijli on Friday said he expects the merger with Inox Leisure to be completed by the end of this fiscal.

Khelraja signs Esha Gupta as brand ambassador

Dec 11, 2022

Khelraja’s latest association comes close on the heels of its partnership with Manchester United and France legend Patrice Evra and is a momentous development for the growth of the Khelraja brand as well as Southeast Asia’s larger iGaming ecosystem.

Steel Prices to rebound in first half of 2023, CEO of Canadian Steelmaker says

Dec 17, 2022

Steel prices have fallen more than 50 percent this year, including an almost 15 percent decline in the last three months.

Kotak, METRO Cash & Carry India launch METRO Kotak Credit Card

Dec 16, 2022

This card will provide an easy, interest-free credit facility, for up to 48 days to over 3 million registered METRO India customers. The card has been launched on the RuPay network.